Fetal valproate syndrome with coronary arteriovenous fistula: a case report

Cardiol Young. 2021 May;31(5):853-855. doi: 10.1017/S1047951120004904. Epub 2021 Jan 18.

Abstract

Interestingly, our case presenting with coronary AV fistula firstly reported in the literature with fetal valproate syndrome. Although differential diagnosis is sometimes difficult, it can be diagnosed with detailed history, physical examination and appropriate laboratory tests. Fetal valproate syndrome can be prevented by discontinue of the valproic acid especially during first trimester of pregnancy.

Keywords: coronary AV fistula; fetal valproate syndrome; teratogenes.

Publication types

  • Case Reports

MeSH terms

  • Abnormalities, Drug-Induced*
  • Arteriovenous Fistula*
  • Female
  • Humans
  • Pregnancy
  • Pregnancy Trimester, First
  • Valproic Acid / adverse effects

Substances

  • Valproic Acid

Supplementary concepts

  • Valproic acid antenatal infection